早期宫颈癌微创根治性子宫切除术的系统评价与荟萃分析
结果显示微创手术与更差的无进展生存期相关(OR 1.54,95%CI 1.24-1.94),且随访时间越长风险越明显,而总生存期无显著差异。
要点
- 微创根治性子宫切除术与更差的无进展生存期相关(OR 1.54,95%CI 1.24-1.94)。
- 随访超过60个月时,微创手术的无进展生存期风险比达2.020(95%CI 1.36-3.001)。
- 总生存期在微创与开腹手术间无显著差异(OR 0.94,95%CI 0.66-1.35)。
核心结论
- 在50项研究的荟萃分析中,微创根治性子宫切除术与开腹手术相比,早期宫颈癌的无进展生存期更差。
- 该发现随随访时间延长而更加明显,凸显长期高质量研究对指导癌症和手术治疗的重要性。
研究设计与样本
- 系统评价与荟萃分析,检索MEDLINE、Embase、Cochrane对照试验中心注册库和Cochrane图书馆数据库。
- 采用随机效应模型进行整体及按随访时长的荟萃分析。
主要发现
- 微创根治性子宫切除术的无进展生存期几率更差(OR 1.54;95%CI 1.24-1.94;14项研究)。
- 限制于较长随访研究时,微创手术的无进展生存期风险比逐渐变差:>36个月HR 1.48(95%CI 1.21-1.82;10项研究);>48个月HR 1.69(95%CI 1.26-2.27;5项研究);>60个月HR 2.020(95%CI 1.36-3.001;3项研究)。
- 总生存期在微创与开腹手术间无显著差异(OR 0.94;95%CI 0.66-1.35;14项研究);>36个月HR 0.99(95%CI 0.66-1.48;9项研究);>48个月HR 1.05(95%CI 0.57-1.94;4项研究);>60个月HR 1.35(95%CI 0.73-2.51;3项研究)。
关键数值与推荐
- 纳入标准为I期及以上宫颈癌女性,接受初次根治性子宫切除术,并比较微创与开腹手术的复发和/或PFS及总生存期。
- 20%的研究随访时间少于36个月,24%的研究随访时间超过60个月。
临床怎么用
- 对于早期宫颈癌,微创根治性子宫切除术可能与更差的无进展生存期相关,尤其在长期随访中。
- 临床决策时应考虑手术方式对肿瘤学结局的影响,并重视长期随访数据。
局限性
- 纳入研究以队列研究为主,仅1项随机对照试验,存在混杂偏倚可能。
- 部分研究随访时间较短(20%<36个月),可能影响长期结局评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare recurrence rate, progression-free survival (PFS), and overall survival for early-stage cervical cancer after minimally invasive (MIS) vs abdominal radical hysterectomy. DATA SOURCES: MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Cochrane Library databases. METHODS OF STUDY SELECTION: We identified studies from 1990 to 2020 that included women with stage I or higher cervical cancer treated with primary radical hysterectomy and compared recurrence and/or PFS and overall survival with MIS vs abdominal radical hysterectomy. (The review protocol was registered with the International Prospective Register of Systematic Reviews: CRD4202173600). TABULATION, INTEGRATION, AND RESULTS: We performed random-effects meta-analyses overall and by length of follow-up. Fifty articles on 40 cohort studies and 1 randomized controlled trial that included 22 593 women with cervical cancer met the inclusion criteria. Twenty percent of the studies had <36 months of follow-up, and 24% had more than 60 months of follow-up. The odds of PFS were worse for women undergoing MIS radical hysterectomy (odds ratio 1.54; 95% CI [confidence interval], 1.24-1.94; 14 studies). When limited to studies with longer follow-up, the odds of PFS were progressively worse with MIS radical hysterectomy (HR [hazard ratio] 1.48 for >36 months; 95% CI, 1.21-1.82; 10 studies; HR 1.69 for >48 months; 95% CI, 1.26-2.27; 5 studies; and HR 2.020 for >60 months; 95% CI, 1.36-3.001; 3 studies). For overall survival, the odds were not significantly different for MIS vs abdominal hysterectomy (odds ratio 0.94; 95% CI, 0.66-1.35; 14 studies) (HR 0.99 for >36 months; 95% CI, 0.66-1.48; 9 studies; HR 1.05 for >48 months; 95% CI, 0.57-1.94; 4 studies; and HR 1.35 for >60 months; 95% CI, 0.73-2.51; 3 studies). CONCLUSION: In our meta-analysis of 50 studies, MIS radical hysterectomy was associated with worse PFS than open radical hysterectomy for early-stage cervical cancer. The emergence of this finding with longer follow-up highlights the importance of long-term, high-quality studies to guide cancer and surgical treatments.
引用
- Smith AJB, Jones TN, Miao D, et al. Minimally Invasive Radical Hysterectomy for Cervical Cancer: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2020. PMID: 33359291. doi:10.1016/j.jmig.2020.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。